Formycon Plans Ranibizumab Filings With Ustekinumab And Aflibercept In The Wings

 
• By Aidan Fry
Submit
Formycon is gearing up to file its FYB201 ranibizumab biosimilar candidate for approval in the US and the EU • Source: Shutterstock

More from Biosimilars

More from Products